Aina Bellver‐Sanchís

593 total citations · 1 hit paper
24 papers, 404 citations indexed

About

Aina Bellver‐Sanchís is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Aina Bellver‐Sanchís has authored 24 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 11 papers in Physiology and 6 papers in Pharmacology. Recurrent topics in Aina Bellver‐Sanchís's work include Alzheimer's disease research and treatments (9 papers), Epigenetics and DNA Methylation (9 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Aina Bellver‐Sanchís is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Epigenetics and DNA Methylation (9 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Aina Bellver‐Sanchís collaborates with scholars based in Spain, India and United States. Aina Bellver‐Sanchís's co-authors include Christian Griñán‐Ferré, Mercè Pallàs, Coral Sanfeliu, Miguel Chillón, Santiago Vázquez, Csaba Sőti, Rubén Corpas, Milán Somogyvári, Cristina Andrés‐Lacueva and Júlia Companys‐Alemany and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Aina Bellver‐Sanchís

24 papers receiving 397 citations

Hit Papers

The pleiotropic neuroprotective effects of resveratrol in... 2021 2026 2022 2024 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: From antioxidant to epigenetic therapy
    2021 166 citations Christian Griñán‐Ferré, Aina Bellver‐Sanchís et al. Ageing Research Reviews profile →

Peers

Aina Bellver‐Sanchís
M O Kim South Korea
Bruno Dutra Arbo Brazil
Manish Kumar Tripathi Israel
Lígia Fão Portugal
Li An China
Ying Song China
Joanna Wojsiat Poland
Yue Dong China
Esraa A. Kandil Egypt
Shubham Upadhayay India
M O Kim South Korea
Aina Bellver‐Sanchís
Citations per year, relative to Aina Bellver‐Sanchís Aina Bellver‐Sanchís (= 1×) peers M O Kim

Countries citing papers authored by Aina Bellver‐Sanchís

Since Specialization
Citations

This map shows the geographic impact of Aina Bellver‐Sanchís's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aina Bellver‐Sanchís with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aina Bellver‐Sanchís more than expected).

Fields of papers citing papers by Aina Bellver‐Sanchís

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aina Bellver‐Sanchís. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aina Bellver‐Sanchís. The network helps show where Aina Bellver‐Sanchís may publish in the future.

Co-authorship network of co-authors of Aina Bellver‐Sanchís

This figure shows the co-authorship network connecting the top 25 collaborators of Aina Bellver‐Sanchís. A scholar is included among the top collaborators of Aina Bellver‐Sanchís based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aina Bellver‐Sanchís. Aina Bellver‐Sanchís is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lillo, Jaume, Christian Griñán‐Ferré, Aina Bellver‐Sanchís, et al.. (2025). Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer's disease pathology and enhancing cognitive function. Alzheimer s Research & Therapy. 17(1). 109–109. 2 indexed citations
3.
Bellver‐Sanchís, Aina, Marta Alegret, Emma Barroso, et al.. (2025). FTO inhibition mitigates high-fat diet-induced metabolic disturbances and cognitive decline in SAMP8 mice. Molecular Medicine. 31(1). 73–73. 2 indexed citations
4.
Bellver‐Sanchís, Aina, et al.. (2025). G9a an Epigenetic Therapeutic Strategy for Neurodegenerative Conditions: From Target Discovery to Clinical Trials. Medicinal Research Reviews. 45(3). 985–1015. 4 indexed citations
5.
Bellver‐Sanchís, Aina, Sunil Kumar, Belén Pérez, et al.. (2024). Design, synthesis, and biological evaluation of tetrahydropyrimidine analogue as GSK-3β/Aβ aggregation inhibitor and anti-Alzheimer’s agent. Bioorganic Chemistry. 153. 107811–107811. 3 indexed citations
6.
Griñán‐Ferré, Christian, Aina Bellver‐Sanchís, Emma Barroso, et al.. (2024). Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks. International Journal of Molecular Sciences. 25(5). 2595–2595. 5 indexed citations
7.
Bellver‐Sanchís, Aina, Gemma Navarro, Júlia Companys‐Alemany, et al.. (2024). G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer’s Disease. Aging and Disease. 15(1). 311–311. 6 indexed citations
8.
Griñán‐Ferré, Christian, Aina Bellver‐Sanchís, Ana Guerrero, & Mercè Pallàs. (2024). Advancing personalized medicine in neurodegenerative diseases: The role of epigenetics and pharmacoepigenomics in pharmacotherapy. Pharmacological Research. 205. 107247–107247. 19 indexed citations
9.
Miró, Lluïsa, Aina Bellver‐Sanchís, Christian Griñán‐Ferré, et al.. (2024). Nutritional, molecular, and functional properties of a novel enzymatically hydrolyzed porcine plasma product. PLoS ONE. 19(5). e0301504–e0301504. 1 indexed citations
10.
Griñán‐Ferré, Christian, Verónica Palomera‐Ávalos, Júlia Companys‐Alemany, et al.. (2024). Changes in Gene Expression Profile with Age in SAMP8: Identifying Transcripts Involved in Cognitive Decline and Sporadic Alzheimer’s Disease. Genes. 15(11). 1411–1411. 1 indexed citations
11.
Bellver‐Sanchís, Aina, et al.. (2023). Repurposing of Raltitrexed as an Effective G9a/EHMT2 Inhibitor and Promising Anti-Alzheimer’s Agent. ACS Medicinal Chemistry Letters. 14(11). 1531–1536. 5 indexed citations
12.
Griñán‐Ferré, Christian, Aina Bellver‐Sanchís, Dolors Puigoriol‐Illamola, et al.. (2023). Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics. CNS Neuroscience & Therapeutics. 30(4). e14511–e14511. 9 indexed citations
13.
14.
Bellver‐Sanchís, Aina, Júlia Companys‐Alemany, Verónica Palomera‐Ávalos, et al.. (2022). Cognitive Decline and BPSD Are Concomitant with Autophagic and Synaptic Deficits Associated with G9a Alterations in Aged SAMP8 Mice. Cells. 11(16). 2603–2603. 15 indexed citations
15.
Bellver‐Sanchís, Aina, Júlia Companys‐Alemany, Ruchi Malik, et al.. (2022). Structure‐Based Virtual Screening and in vitro and in vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti‐Alzheimer's Agents. ChemMedChem. 17(13). e202200002–e202200002. 12 indexed citations
16.
Bellver‐Sanchís, Aina, Mercè Pallàs, & Christian Griñán‐Ferré. (2021). The Contribution of Epigenetic Inheritance Processes on Age-Related Cognitive Decline and Alzheimer’s Disease. Epigenomes. 5(2). 15–15. 14 indexed citations
17.
18.
Griñán‐Ferré, Christian, Aina Bellver‐Sanchís, Rubén Corpas, et al.. (2021). The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: From antioxidant to epigenetic therapy. Ageing Research Reviews. 67. 101271–101271. 166 indexed citations breakdown →
19.
Bellver‐Sanchís, Aina, Marta D. Costa, Mark A. Varney, et al.. (2021). Identification of the 5-HT1A serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph disease. Neurobiology of Disease. 152. 105278–105278. 9 indexed citations
20.
Pawar, Shrikant, Aina Bellver‐Sanchís, & Christian Griñán‐Ferré. (2021). RNA-seq and miRNA-seq data from pharmacological inhibition of the G9a/GLP histone methyltransferase complex with UNC0642 in SAMP8 mice. SHILAP Revista de lepidopterología. 36. 107114–107114. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M O Kim Breakdown of academic impact, for papers by Bruno Dutra Arbo Breakdown of academic impact, for papers by Manish Kumar Tripathi Breakdown of academic impact, for papers by Lígia Fão Breakdown of academic impact, for papers by Li An Breakdown of academic impact, for papers by Ying Song Breakdown of academic impact, for papers by Joanna Wojsiat Breakdown of academic impact, for papers by Yue Dong Breakdown of academic impact, for papers by Esraa A. Kandil Breakdown of academic impact, for papers by Shubham Upadhayay
Rankless by CCL
2026